Provident Investment Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-82,099
| Closed | -$24.7M | – | 55 |
|
|
2018
Q4 | $24.7M | Sell |
82,099
-2,562
| -3% | -$771K | 4.41% | 11 |
|
|
2018
Q3 | $29.9M | Sell |
84,661
-2,505
| -3% | -$885K | 4.25% | 13 |
|
|
2018
Q2 | $25.3M | Buy |
87,166
+4,336
| +5% | +$1.26M | 3.59% | 17 |
|
|
2018
Q1 | $22.7M | Buy |
82,830
+15,874
| +24% | +$4.35M | 3.58% | 18 |
|
|
2017
Q4 | $21.3M | Buy |
66,956
+472
| +0.7% | +$150K | 3.41% | 18 |
|
|
2017
Q3 | $20.8M | Buy |
66,484
+128
| +0.2% | +$40.1K | 3.53% | 19 |
|
|
2017
Q2 | $18M | Buy |
66,356
+1,044
| +2% | +$283K | 3.28% | 19 |
|
|
2017
Q1 | $17.9M | Sell |
65,312
-145
| -0.2% | -$39.6K | 3.32% | 19 |
|
|
2016
Q4 | $18.6M | Sell |
65,457
-444
| -0.7% | -$126K | 3.6% | 18 |
|
|
2016
Q3 | $20.6M | Sell |
65,901
-189
| -0.3% | -$59.2K | 4.28% | 14 |
|
|
2016
Q2 | $16M | Buy |
66,090
+1,191
| +2% | +$288K | 3.29% | 19 |
|
|
2016
Q1 | $16.9M | Buy |
64,899
+3,004
| +5% | +$782K | 3.38% | 18 |
|
|
2015
Q4 | $19M | Buy |
61,895
+10,645
| +21% | +$3.26M | 3.81% | 16 |
|
|
2015
Q3 | $15M | Buy |
+51,250
| New | +$15M | 3.13% | 16 |
|